ArticleJournal of nanobiotechnology2026

A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling.

Andrew E-Y Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.